International Psoriasis Council

Advancing Knowledge. Improving Care.

A wide view of the Obelisco and a busy Buenos Aires avenue with RADLA 2026, SOARPSO, and SOLAPSO event logos, plus an IPC education diversity badge in the top left corner.

IPC/SOLAPSO/SOARPSO Education Partnership: Clinical Challenges in Psoriasis: When Severity, Timing, and Age Matter

XLIII REUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | BUENOS AIRES, ARGENTINA

May 19, 2026
 | 14:00 – 15:30 ART
Location: Centro de Convenciones de la Ciudad de Buenos Aires

Add event to calendar
Apple   Google   Outlook   Outlook.com   Office 365   Yahoo

Agenda

Welcome and Introduction to Session
Co-chairs

SESSION ONE: DISEASE SEVERITY

Topical Therapy Failure

César Gonzalez, MD, Colombia

High Impact Sites
Cristina Echeverría, MD, Argentina

Panel Q&A

SESSION TWO: PSORIASIS & EARLY INTERVENTION

Discussion: Immunopathogenesis and the Window of Opportunity for Early Effective Treatment
& PsA Prevention
Maria Victoria Suarez Restrepo, MD, Brazil
Fernando Valenzuela, MD, Chile

Panel Q&A

SESSION THREE: PEDIATRIC PSORIASIS

Early Intervention in Pediatric Psoriasis: Implications for Metabolic Health and Comorbidities
Paula Carolina Luna, MD, Argentina

Psoriasis and the Psychological Impact on Childhood and Beyond
Benjamin Hidalgo Matlock, Costa Rica

Panel Q&A

Conclusion
Co-chairs

Program Chairs

Carolina Ledesma, MD

Medicina y Estética Salta

City of Salta, Argentina

Bio

Maria Victoria Suarez Restrepo, MD

Hospital do Servidor Publico Municipal de São Paulo

São Paulo, Brazil

IPC Councilor

Bio

Fernando Valenzuela, MD

University of Chile, University of the Andes

Santiago, Chile

IPC Councilor

Bio

Program Faculty

Cristina Echeverría, MD

Instituto de Rehabilitación Psicofísica (IREP)

Buenos Aires, Argentina

IPC Councilor

Bio

César Gonzalez, MD

Clinica Universitaria Colombia

Bogota, Colombia

IPC Councilor

Bio

Benjamin Hidalgo Matlock, MD

Universidad de Costa Rica / Universidad Latina de Costa Rica, Hospital Nacional de Niños, and Skin Care Physicians of Costa Rica

San Jose, Costa Rica

IPC Councilor

Bio

Paula Carolina Luna, MD

Hospital Aleman

Capital Federal, Argentina

IPC Councilor

Bio

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026